-+ 0.00%
-+ 0.00%
-+ 0.00%

Eton Pharmaceuticals FY2026 Revenue expected to be more than $175.000M vs $149.702M Est

Benzinga·11/05/2026 21:22:32
语音播报
Eton Pharmaceuticals (NASDAQ:ETON) FY2026 Revenue expected to be more than $175.000M vs $149.702M Est